Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | AMPH | TSHA | ||
| Company | Supernus Pharm | Amphastar Pharma | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.08 | 45.48 | 2.20 | ||
| High | 36.66 | 45.65 | 2.62 | ||
| Low | 35.85 | 44.95 | 2.12 | ||
| Last | 36.22 | 45.46 | 2.47 | ||
| Change | +0.40 | +0.91 | +0.29 | ||
| % Change | +1.12% | +2.04% | +13.30% | ||
| Volume | 208,100 | 410,700 | 9,792,400 | ||
| 20-Day Average Volume | 424,035 | 426,480 | 7,314,755 | ||
| Previous Close | 35.82 | 44.55 | 2.18 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 35.73 | 47.89 | 1.87 | ||
| 20-Day Raw Stochastic | 46.97% | 21.81% | 88.89% | ||
| 20-Day Relative Strength | 57.29% | 44.39% | 59.96% | ||
| Weighted Alpha | +34.49 | -15.58 | -6.40 | ||
| Today's Opinion | 100% Buy | 24% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.83% since 11/15/24 | +1.91% since 11/15/24 | +19.90% since 11/15/24 | ||
| Low | 34.86 on 11/18/24 | 43.09 on 11/20/24 | 1.96 on 11/20/24 | ||
| High | 36.66 on 11/22/24 | 45.65 on 11/22/24 | 2.62 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +7.45% since 10/22/24 | -9.77% since 10/22/24 | +24.12% since 10/22/24 | ||
| Low | 33.35 on 10/23/24 | 43.09 on 11/20/24 | 1.19 on 11/05/24 | ||
| High | 39.37 on 11/05/24 | 53.96 on 11/06/24 | 2.63 on 11/14/24 | ||
| 3-Month | |||||
| %Chg | +5.17% since 08/22/24 | -3.75% since 08/22/24 | +10.27% since 08/22/24 | ||
| Low | 29.50 on 09/11/24 | 43.09 on 11/20/24 | 1.19 on 11/05/24 | ||
| High | 39.37 on 11/05/24 | 53.96 on 11/06/24 | 2.63 on 11/14/24 | ||
| 6-Month | |||||
| %Chg | +29.96% since 05/22/24 | +4.60% since 05/22/24 | -16.84% since 05/22/24 | ||
| Low | 25.53 on 06/14/24 | 36.56 on 07/09/24 | 1.19 on 11/05/24 | ||
| High | 39.37 on 11/05/24 | 53.96 on 11/06/24 | 4.32 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,000,032 | 2,185,762 | 506,209 | ||
| Shares Outstanding, K | 55,219 | 48,081 | 204,943 | ||
| Annual Sales | 607,520,000 | 644,400,000 | 15,450,000 | ||
| Annual Net Income | 1,320,000 | 137,550,000 | -111,570,000 | ||
| Last Quarter Sales | 175,690,000 | 191,210,000 | 1,790,000 | ||
| Last Quarter Net Income | 38,500,000 | 40,430,000 | -25,520,000 | ||
| 60-Month Beta | 0.86 | 0.82 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.06 on 11/04/24 | 0.96 on 11/06/24 | -0.09 on 11/13/24 | ||
| Latest Earnings Date | 11/04/24 | 11/06/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 26.93 | 12.88 | 31.14 | ||